Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Top Story

CV Therapeutics raises $85.5 million

August 17, 2006 1:14 AM UTC

CVTX raised $85.5 million through the sale of 9 million shares at $9.50 in a bumped-up follow-on underwritten by Lehman and Merrill Lynch. CVTX proposed to sell 7.5 million shares earlier this week, w...